619 related articles for article (PubMed ID: 30142879)
21. Stimulation and Inhibition of Lymphangiogenesis Via Adeno-Associated Viral Gene Delivery.
Karaman S; Nurmi H; Antila S; Alitalo K
Methods Mol Biol; 2018; 1846():291-300. PubMed ID: 30242767
[TBL] [Abstract][Full Text] [Related]
22. Regulation of CCN2/CTGF and related cytokines in cultured peritoneal cells under conditions simulating peritoneal dialysis.
Leung JC; Chan LY; Tam KY; Tang SC; Lam MF; Cheng AS; Chu KM; Lai KN
Nephrol Dial Transplant; 2009 Feb; 24(2):458-69. PubMed ID: 18805993
[TBL] [Abstract][Full Text] [Related]
23. CPT1A regulates breast cancer-associated lymphangiogenesis via VEGF signaling.
Xiong Y; Liu Z; Zhao X; Ruan S; Zhang X; Wang S; Huang T
Biomed Pharmacother; 2018 Oct; 106():1-7. PubMed ID: 29940537
[TBL] [Abstract][Full Text] [Related]
24. Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation.
Baluk P; Tammela T; Ator E; Lyubynska N; Achen MG; Hicklin DJ; Jeltsch M; Petrova TV; Pytowski B; Stacker SA; Ylä-Herttuala S; Jackson DG; Alitalo K; McDonald DM
J Clin Invest; 2005 Feb; 115(2):247-57. PubMed ID: 15668734
[TBL] [Abstract][Full Text] [Related]
25. DNA demethylation of vascular endothelial growth factor-C is associated with gene expression and its possible involvement of lymphangiogenesis in gastric cancer.
Matsumura S; Oue N; Mitani Y; Kitadai Y; Yasui W
Int J Cancer; 2007 Apr; 120(8):1689-95. PubMed ID: 17230534
[TBL] [Abstract][Full Text] [Related]
26. Transgenic induction of vascular endothelial growth factor-C is strongly angiogenic in mouse embryos but leads to persistent lymphatic hyperplasia in adult tissues.
Lohela M; Heloterä H; Haiko P; Dumont DJ; Alitalo K
Am J Pathol; 2008 Dec; 173(6):1891-901. PubMed ID: 18988807
[TBL] [Abstract][Full Text] [Related]
27. The VEGF-C/VEGFR3 signaling pathway contributes to resolving chronic skin inflammation by activating lymphatic vessel function.
Hagura A; Asai J; Maruyama K; Takenaka H; Kinoshita S; Katoh N
J Dermatol Sci; 2014 Feb; 73(2):135-41. PubMed ID: 24252749
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-8: A potent promoter of human lymphatic endothelial cell growth in gastric cancer.
Shi J; Li YJ; Yan B; Wei PK
Oncol Rep; 2015 Jun; 33(6):2703-10. PubMed ID: 25891418
[TBL] [Abstract][Full Text] [Related]
29. Efficient activation of the lymphangiogenic growth factor VEGF-C requires the C-terminal domain of VEGF-C and the N-terminal domain of CCBE1.
Jha SK; Rauniyar K; Karpanen T; Leppänen VM; Brouillard P; Vikkula M; Alitalo K; Jeltsch M
Sci Rep; 2017 Jul; 7(1):4916. PubMed ID: 28687807
[TBL] [Abstract][Full Text] [Related]
30. Molecular targeting of lymphatics for therapy.
Stacker SA; Hughes RA; Achen MG
Curr Pharm Des; 2004; 10(1):65-74. PubMed ID: 14754406
[TBL] [Abstract][Full Text] [Related]
31. Connective tissue growth factor (CTGF/CCN2) is increased in peritoneal dialysis patients with high peritoneal solute transport rate.
Mizutani M; Ito Y; Mizuno M; Nishimura H; Suzuki Y; Hattori R; Matsukawa Y; Imai M; Oliver N; Goldschmeding R; Aten J; Krediet RT; Yuzawa Y; Matsuo S
Am J Physiol Renal Physiol; 2010 Mar; 298(3):F721-33. PubMed ID: 20015945
[TBL] [Abstract][Full Text] [Related]
32. Neuroblastoma progression correlates with downregulation of the lymphangiogenesis inhibitor sVEGFR-2.
Becker J; Pavlakovic H; Ludewig F; Wilting F; Weich HA; Albuquerque R; Ambati J; Wilting J
Clin Cancer Res; 2010 Mar; 16(5):1431-41. PubMed ID: 20179233
[TBL] [Abstract][Full Text] [Related]
33. Lymphangiogenesis in chronic inflammation in the testis.
Hirai S; Naito M; Terayama H; Qu N; Kuerban M; Musha M; Itoh M
Andrology; 2013 Jan; 1(1):147-54. PubMed ID: 23258644
[TBL] [Abstract][Full Text] [Related]
34. Balance of profibrotic and antifibrotic [corrected] signaling in nephrogenic systemic fibrosis skin lesions.
Schieren G; Gambichler T; Skrygan M; Burkert B; Altmeyer P; Rump LC; Kreuter A
Am J Kidney Dis; 2010 Jun; 55(6):1040-9. PubMed ID: 20430497
[TBL] [Abstract][Full Text] [Related]
35. Inflammation induces lymphangiogenesis through up-regulation of VEGFR-3 mediated by NF-kappaB and Prox1.
Flister MJ; Wilber A; Hall KL; Iwata C; Miyazono K; Nisato RE; Pepper MS; Zawieja DC; Ran S
Blood; 2010 Jan; 115(2):418-29. PubMed ID: 19901262
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-21 promotes the progression of peritoneal fibrosis through the activation of the TGF-β/Smad signaling pathway: An in vitro and in vivo study.
Ma YL; Chen F; Yang SX; Chen BP; Shi J
Int J Mol Med; 2018 Feb; 41(2):1030-1038. PubMed ID: 29207016
[TBL] [Abstract][Full Text] [Related]
37. Vascular endothelial growth factor receptor-3 is a novel target to improve net ultrafiltration in methylglyoxal-induced peritoneal injury.
Terabayashi T; Ito Y; Mizuno M; Suzuki Y; Kinashi H; Sakata F; Tomita T; Iguchi D; Tawada M; Nishio R; Maruyama S; Imai E; Matsuo S; Takei Y
Lab Invest; 2015 Sep; 95(9):1029-43. PubMed ID: 26121315
[TBL] [Abstract][Full Text] [Related]
38. Vascular endothelial growth factor (VEGF)-C, VEGF-D, VEGFR-3 and D2-40 expressions in primary breast cancer: Association with lymph node metastasis.
Eroğlu A; Ersöz C; Karasoy D; Sak S
Adv Clin Exp Med; 2017; 26(2):245-249. PubMed ID: 28791841
[TBL] [Abstract][Full Text] [Related]
39. Roles of VEGF-C and Smad4 in the lymphangiogenesis, lymphatic metastasis, and prognosis in colon cancer.
Li X; Liu B; Xiao J; Yuan Y; Ma J; Zhang Y
J Gastrointest Surg; 2011 Nov; 15(11):2001-10. PubMed ID: 21786062
[TBL] [Abstract][Full Text] [Related]
40. Profound but dysfunctional lymphangiogenesis via vascular endothelial growth factor ligands from CD11b+ macrophages in advanced ovarian cancer.
Jeon BH; Jang C; Han J; Kataru RP; Piao L; Jung K; Cha HJ; Schwendener RA; Jang KY; Kim KS; Alitalo K; Koh GY
Cancer Res; 2008 Feb; 68(4):1100-9. PubMed ID: 18281485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
